
Following its recent $16.5 million Series A financing in December, Ember LifeSciences, Inc. announced the appointment of Ann Hyllengren as Chief Financial Officer to support the company's next phase of growth.
"We are thrilled to welcome Ann at a pivotal stage in our evolution," said Clay Alexander, founder and CEO of Ember LifeSciences. "She brings deep financial and operational leadership experience at one of the top life science companies in the world and will be instrumental as we develop and launch new reliable, sustainable cold chain solutions for life sciences, and beyond."
"I am excited to join a team that is working to solve one of the healthcare industry's most costly challenges, with a clear focus on sustainability and improving patient outcomes," said Ann Hyllengren. "Ember is creating a disruptive and positive impact across the life sciences supply chain, and I look forward to supporting the company's operational scale and market expansion."
The global pharmaceutical cold chain ecosystem faces $35 billion in financial loss each year due to temperature excursions. Ember addresses this challenge with its Ember Cube, a first-of-its-kind digital shipping box that features cloud-based temperature reporting, GPS location tracking and sustainable return-to-sender technology.
Prior to joining Amgen, Hyllengren worked in external reporting at Dole Food Company and began her career in assurance and business advisory services at PricewaterhouseCoopers LLP. She also served as an adjunct professor at Moorpark College and the University of La Verne. Hyllengren is an active Certified Public Accountant and holds a Master of Accounting from the University of Southern California and a Bachelor of Arts in Business Management Economics from the University of California, Santa Cruz.